A SEVERE CASE WITH RELAPSING BULLOUS TOXICODERMA


Cite item

Full Text

Abstract

Toxic epidermal necrolysis in a female patient aged 68 years was caused by therapy with SH group containing drugs. The patient was treated by metiprede in the maximum daily dose of 48 mg, which was gradually reduced as a significant improvement was attained.

About the authors

O. Yu Olisova

ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздрава России

д-р мед. наук, проф.

A. A Khaldin

ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздрава России

Email: khaldinderma@yandex.ru
д-р мед. наук, проф.

N. P Teplyuk

ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздрава России

д-р мед. наук., проф.

O. V Grabovskaya

ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздрава России

канд. мед. наук, врач

D. V Ignatyev

ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздрава России

врач

E. Yu Vertieva

ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздрава России

врач

References

  1. Chung W.H., Hung S.I., Yang J.Y., Su S.C., Huang S.P., Wei C.Y., et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat. Med. 2008; 14(12): 1343—50.
  2. Sun-Hee Choi, Yu-Min Lee, Yeong-Ho Rha Korean J. Pediatr. 2009; 52(2): 247—50.
  3. Grosber M., Carsin H., Leclerc F. Epidermal necrolysis in association with Mycoplasma pneumonia infection. J. Invest. Dermatol. 2006, 126(1): 23.
  4. Guégan S., Bastuji-Garin S., Poszepczynka-Guigne E., Roujeau J.C., Revuz J. Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis. J. Invest. Dermatol. 2006; 126(2): 272—6.
  5. Lonjou C., Thomas L., Borot N., Ledger N., de Toma C., LeLouet H., et al.; RegiSCAR Group. A marker for Stevens-Johnson syndrome..: ethnicity matters. Pharmacogenomics J. 2006; 6(4): 265—8.
  6. Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br. J. Dermatol. 1956; 68(11): 355—61.
  7. Magina S., Lisboa C., Leal V., Palmares J., Mesquita-Guimames J. Dermatological and ophthalmological sequels in toxic epidermal necrolysis. Dermatology 2003; 207(1): 33—6.
  8. Mockenhaupt M. Severe cutaneous adverse reactions. Braun-Falco’s Dermatology Heidelberg: Springer Medizin Verlag; 2008: 473—83.
  9. Mockenhaupt M. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis Expert. Rev. Clin. Immunol. 2011; 7(6): 803—15.
  10. Revuz J., Penso D., Roujeau J.C., Guillaume J.C., Payne C.R., Wechsler J., Touraine R. Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch. Dermatol. 1987; 123(9): 1160—5.

Copyright (c) 2012 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies